• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体重指数和手臂人体测量学与血液系统恶性肿瘤患儿异基因造血细胞移植后结局的关系。

Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.

机构信息

Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

出版信息

Biol Blood Marrow Transplant. 2013 Jul;19(7):1081-6. doi: 10.1016/j.bbmt.2013.04.017. Epub 2013 Apr 25.

DOI:10.1016/j.bbmt.2013.04.017
PMID:23623893
Abstract

Although nutritional status may adversely affect various health outcomes, the relationship between anthropometry and outcomes after hematopoietic cell transplantation (HCT) has not been fully studied in children. We analyzed the impact of pre-HCT body mass index (BMI), arm muscle area, and arm fat area on outcomes in 733 patients age 2-18 years who underwent allogeneic HCT for a hematologic malignancy between 1985 and 2009. We evaluated these 3 variables according to patient group based on age- and sex-adjusted percentiles for BMI, arm muscle area (<5th, 5th-24th, 25th-94th, and ≥95th), and arm fat area (<25th, 25th-94th, and ≥95th). Cox proportional hazards regression models for event-free survival (EFS), relapse, and nonrelapse mortality (NRM) at 100 days and 3 years after HCT, as well as grade II-IV acute graft-versus-host disease (GVHD) and chronic GVHD, were performed using the 3 major variables and adjusted for covariates. BMI was <5th percentile in only 3% of patients and ≥95th percentile in 15% of patients, but outcomes for both groups were similar to those for the BMI 25th-94th percentile group. The BMI 5th-24th percentile group had lower EFS (P = .01) and higher relapse (P = .003) at day +100 post-HCT, but these associations did not hold at 3 years post-HCT. Arm muscle area was <5th percentile in 8% of patients, and arm fat area was <25th percentile in 10%. Analysis of arm muscle area showed that the <5th percentile group had lower EFS and higher NRM and relapse rate at day +100 (P = .002, .04, and .01, respectively) and 3 years (P = .0004, .008, and .01, respectively) post-HCT. Arm fat area <25th percentile was associated with lower EFS at day +100 (hazard ratio, 1.5; P = .05), but not at 3 years post-HCT. Anthropometry variables were not associated with acute or chronic GVHD. In conclusion, arm muscle area <5th percentile appears to be a stronger predictor than BMI of poor outcomes after HCT in children with hematologic malignancies.

摘要

尽管营养状况可能会对各种健康结果产生不利影响,但在儿童中,人体测量学与造血细胞移植(HCT)后的结果之间的关系尚未得到充分研究。我们分析了 733 名 2-18 岁接受血液恶性肿瘤异基因 HCT 的患者的预 HCT 体重指数(BMI)、手臂肌肉面积和手臂脂肪面积对结局的影响,这些患者于 1985 年至 2009 年之间进行。我们根据患者年龄和性别调整后的 BMI、手臂肌肉面积(<5th、5th-24th、25th-94th 和≥95th)和手臂脂肪面积(<25th、25th-94th 和≥95th)的百分位数,根据患者组评估了这 3 个变量。使用 3 个主要变量和调整后的协变量,对 100 天和 3 年后无事件生存(EFS)、复发和非复发死亡率(NRM)、2 级-4 级急性移植物抗宿主病(GVHD)和慢性 GVHD 的 Cox 比例风险回归模型进行了分析。仅 3%的患者 BMI<5th 百分位,15%的患者 BMI≥95th 百分位,但这两组的结果与 BMI 25th-94th 百分位组相似。BMI 5th-24th 百分位组在 HCT 后第 100 天的 EFS 较低(P=0.01),复发率较高(P=0.003),但在 3 年后这些相关性不再成立。8%的患者手臂肌肉面积<5th 百分位,10%的患者手臂脂肪面积<25 百分位。手臂肌肉面积分析显示,<5th 百分位组在第 100 天(P=0.002、0.04 和 0.01)和 3 年(P=0.0004、0.008 和 0.01)时 EFS 较低,NRM 和复发率较高。手臂脂肪面积<25 百分位与第 100 天 EFS 较低相关(危险比,1.5;P=0.05),但与 3 年后无关。人体测量学变量与急性或慢性 GVHD 无关。总之,手臂肌肉面积<5th 百分位似乎比 BMI 更能预测儿童血液恶性肿瘤患者 HCT 后的不良结局。

相似文献

1
Relationship of body mass index and arm anthropometry to outcomes after pediatric allogeneic hematopoietic cell transplantation for hematologic malignancies.体重指数和手臂人体测量学与血液系统恶性肿瘤患儿异基因造血细胞移植后结局的关系。
Biol Blood Marrow Transplant. 2013 Jul;19(7):1081-6. doi: 10.1016/j.bbmt.2013.04.017. Epub 2013 Apr 25.
2
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.异基因反应性作为血液系统恶性肿瘤治疗的治疗原则。非清髓性预处理的异基因造血细胞移植的临床和免疫学方面的研究。
Dan Med Bull. 2007 May;54(2):112-39.
3
Cotransplantation of mesenchymal stem cells might prevent death from graft-versus-host disease (GVHD) without abrogating graft-versus-tumor effects after HLA-mismatched allogeneic transplantation following nonmyeloablative conditioning.间充质干细胞共移植可能在非清髓性预处理 HLA mismatched 异基因移植后防止移植物抗宿主病 (GVHD) 导致的死亡,而不会消除移植物抗肿瘤效应。
Biol Blood Marrow Transplant. 2010 Jun;16(6):838-47. doi: 10.1016/j.bbmt.2010.01.011. Epub 2010 Jan 28.
4
Impact of postgrafting immunosuppressive regimens on nonrelapse mortality and survival after nonmyeloablative allogeneic hematopoietic stem cell transplant using the fludarabine and low-dose total-body irradiation 200-cGy.使用氟达拉滨和200厘戈瑞低剂量全身照射的非清髓性异基因造血干细胞移植后,移植后免疫抑制方案对非复发死亡率和生存率的影响。
Biol Blood Marrow Transplant. 2007 Jul;13(7):790-805. doi: 10.1016/j.bbmt.2007.03.002. Epub 2007 Apr 23.
5
Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.小儿复发性血液系统恶性肿瘤患者第二次造血干细胞移植后的结局
Biol Blood Marrow Transplant. 2015 Jul;21(7):1266-72. doi: 10.1016/j.bbmt.2015.02.024. Epub 2015 Mar 10.
6
Comparison of two pretransplant predictive models and a flexible HCT-CI using different cut off points to determine low-, intermediate-, and high-risk groups: the flexible HCT-CI Is the best predictor of NRM and OS in a population of patients undergoing allo-RIC.比较两种移植前预测模型和使用不同截断点的灵活 HCT-CI,以确定低、中、高危组:在接受 allo-RIC 的患者人群中,灵活 HCT-CI 是 NRM 和 OS 的最佳预测因子。
Biol Blood Marrow Transplant. 2010 Mar;16(3):413-20. doi: 10.1016/j.bbmt.2009.11.008. Epub 2009 Nov 14.
7
Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.血液系统恶性肿瘤患者接受减低剂量预处理造血干细胞移植后结局的预测因素:来自法国骨髓移植与细胞治疗协会的10年回顾性分析
Exp Hematol. 2008 May;36(5):535-44. doi: 10.1016/j.exphem.2008.01.017. Epub 2008 Mar 17.
8
Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.在接受传统细胞减灭或降低强度方案的异基因造血细胞移植的未缓解患者中,具有可比的抗白血病/淋巴瘤效果。
Biol Blood Marrow Transplant. 2007 Aug;13(8):932-41. doi: 10.1016/j.bbmt.2007.04.004. Epub 2007 May 29.
9
[Prognostic implications of hematopoietic cell transplantation-specific comorbidity index on non-relapse mortality and overall survival after allogeneic hematopoietic stem cell transplantation].造血细胞移植特异性合并症指数对异基因造血干细胞移植后非复发死亡率和总生存率的预后影响
Zhonghua Xue Ye Xue Za Zhi. 2013 Aug;34(8):659-63. doi: 10.3760/cma.j.issn.0253-2727.2013.08.004.
10
Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.联合造血细胞移植合并症指数和欧洲血液与骨髓移植组评分可更好地对接受低强度异基因造血细胞移植的高危患者进行分层。
Biol Blood Marrow Transplant. 2014 Jan;20(1):66-72. doi: 10.1016/j.bbmt.2013.10.011. Epub 2013 Oct 17.

引用本文的文献

1
Impact of Body Mass Index on Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients: A Single-Center Retrospective Study.体重指数对儿科异基因造血干细胞移植受者结局的影响:单中心回顾性研究。
Nutrients. 2024 Oct 25;16(21):3638. doi: 10.3390/nu16213638.
2
Nutritional status, body composition and diet quality in children with cancer.癌症患儿的营养状况、身体成分和饮食质量
Front Oncol. 2024 Apr 19;14:1389657. doi: 10.3389/fonc.2024.1389657. eCollection 2024.
3
The emerging role of nutritional support in the supportive care of pediatric patients undergoing hematopoietic stem cell transplantation.
营养支持在接受造血干细胞移植的儿科患者支持性护理中的新作用。
Front Nutr. 2023 Feb 15;10:1075778. doi: 10.3389/fnut.2023.1075778. eCollection 2023.
4
Weight loss in children undergoing allogeneic hematopoietic stem cell transplantation within the first 100 days: Its influencing factors and impact on clinical outcomes.异基因造血干细胞移植后100天内儿童体重减轻:影响因素及其对临床结局的影响
Front Nutr. 2023 Jan 9;9:974389. doi: 10.3389/fnut.2022.974389. eCollection 2022.
5
Brazilian Nutritional Consensus in Hematopoietic Stem Cell Transplantation: children and adolescents.造血干细胞移植中的巴西坚果营养共识:儿童和青少年。
Einstein (Sao Paulo). 2021 Dec 10;19:eAE5254. doi: 10.31744/einstein_journal/2021AE5254. eCollection 2021.
6
A Review on the Impact of Body Mass Index on Outcomes in Pediatric Leukemia.体重指数对儿童白血病预后影响的综述
J Blood Med. 2020 Jun 18;11:205-212. doi: 10.2147/JBM.S232655. eCollection 2020.
7
Impact of treatment-related weight changes from diagnosis to hematopoietic stem-cell transplantation on clinical outcome of acute myeloid leukemia.从诊断到造血干细胞移植治疗相关体重变化对急性髓系白血病临床结局的影响。
Int J Hematol. 2019 Jun;109(6):673-683. doi: 10.1007/s12185-019-02647-5. Epub 2019 Apr 8.
8
Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation.供体体重指数不能预测造血细胞移植后的移植物抗宿主病。
Bone Marrow Transplant. 2018 Jul;53(7):932-937. doi: 10.1038/s41409-018-0100-1. Epub 2018 Jan 30.
9
Cyclophosphamide leads to persistent deficits in physical performance and in vivo mitochondria function in a mouse model of chemotherapy late effects.在化疗迟发效应的小鼠模型中,环磷酰胺会导致身体机能和体内线粒体功能出现持续性缺陷。
PLoS One. 2017 Jul 10;12(7):e0181086. doi: 10.1371/journal.pone.0181086. eCollection 2017.
10
Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantation.移植前铁蛋白、白蛋白和血红蛋白可独立于异基因干细胞移植后的疾病风险指数预测生存结果。
Bone Marrow Transplant. 2017 Jun;52(6):870-877. doi: 10.1038/bmt.2017.51. Epub 2017 May 15.